The binding of β-arrestin 1 to the endothelin-1 (ET-1)/ET A-type receptor (ETAR) signaling complex, and the activation of β-catenin promote the migration, invasion, and progression of ovarian cancer cells (43). Here, EDNRA is linked to ovarian cancer.